Total Payments
$8,328
2024 Payments
$137.60
Companies
49
Transactions
434
Medicare Patients
2,791
Medicare Billing
$337,982
Payment Breakdown by Category
Food & Beverage$7,992 (96.0%)
Education$207.66 (2.5%)
Other$128.36 (1.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,992 | 424 | 96.0% |
| Education | $207.66 | 3 | 2.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $128.36 | 7 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $796.66 | 36 | $0 (2021) |
| ABBVIE INC. | $667.92 | 55 | $0 (2023) |
| UCB, Inc. | $554.24 | 32 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $521.23 | 23 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $483.17 | 23 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $369.99 | 25 | $0 (2024) |
| GENZYME CORPORATION | $366.03 | 11 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $347.42 | 17 | $0 (2021) |
| Amgen Inc. | $319.45 | 16 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $312.36 | 18 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137.60 | 7 | SK Life Science, Inc. ($79.61) |
| 2023 | $360.05 | 18 | JAZZ PHARMACEUTICALS INC. ($147.03) |
| 2022 | $206.83 | 17 | ABBVIE INC. ($135.22) |
| 2021 | $1,631 | 93 | AbbVie Inc. ($298.05) |
| 2020 | $1,166 | 63 | Biogen, Inc. ($118.65) |
| 2019 | $1,304 | 69 | Genentech USA, Inc. ($191.96) |
| 2018 | $1,678 | 87 | Alexion Pharmaceuticals, Inc. ($294.88) |
| 2017 | $1,844 | 80 | GENZYME CORPORATION ($326.36) |
All Payment Transactions
434 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.36 | General |
| 09/13/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $17.49 | General |
| 07/23/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 05/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Neurology | ||||||
| 04/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Neurology | ||||||
| 03/19/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $25.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/21/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $20.81 | General |
| 12/13/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/17/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.12 | General |
| 10/09/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.38 | General |
| 08/18/2023 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.88 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.28 | General |
| 06/03/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $147.03 | General |
| Category: NEUROLOGY | ||||||
| 06/02/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: NEUROSCIENCE | ||||||
| 05/12/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Neurology | ||||||
| 03/10/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: NEUROSCIENCE | ||||||
| 03/10/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $6.29 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 547 | 644 | $449,397 | $71,686 |
| 2022 | 12 | 426 | 495 | $323,782 | $57,964 |
| 2021 | 16 | 829 | 1,157 | $323,827 | $106,113 |
| 2020 | 17 | 989 | 1,203 | $357,520 | $102,220 |
Total Patients
2,791
Total Services
3,499
Medicare Billing
$337,982
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 158 | 165 | $142,230 | $17,749 | 12.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 70 | 70 | $49,000 | $12,176 | 24.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 95 | 125 | $46,875 | $11,865 | 25.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 52 | 70 | $33,950 | $9,388 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $25,200 | $5,657 | 22.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $40,416 | $4,657 | 11.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 64 | $29,056 | $4,183 | 14.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 14 | 35 | $24,010 | $2,925 | 12.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 22 | $8,120 | $2,197 | 27.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 18 | 19 | $50,540 | $887.68 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 95 | 127 | $48,372 | $12,996 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 60 | $29,710 | $9,172 | 30.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 53 | 53 | $65,255 | $8,629 | 13.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 46 | 46 | $32,465 | $7,827 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $18,991 | $4,247 | 22.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 33 | 35 | $28,445 | $3,968 | 14.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 22 | 39 | $24,774 | $3,074 | 12.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $12,628 | $1,834 | 14.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 16 | 19 | $12,407 | $1,627 | 13.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $6,497 | $1,497 | 23.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 23 | $9,308 | $1,371 | 14.7% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $9,405 | $1,143 | 12.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 12 | 12 | $25,526 | $576.65 | 2.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 216 | 341 | $79,112 | $34,005 | 43.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 96 | 97 | $60,237 | $14,771 | 24.5% |
About Dr. Brian Kelly, MD
Dr. Brian Kelly, MD is a Neurology healthcare provider based in Upland, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164473401.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Kelly, MD has received a total of $8,328 in payments from pharmaceutical and medical device companies, with $137.60 received in 2024. These payments were reported across 434 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($7,992).
As a Medicare-enrolled provider, Kelly has provided services to 2,791 Medicare beneficiaries, totaling 3,499 services with total Medicare billing of $337,982. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Upland, PA
- Active Since 05/12/2006
- Last Updated 01/12/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1164473401
Products in Payments
- SOLIRIS (Drug) $441.25
- TYSABRI (Biological) $373.23
- NUEDEXTA (Drug) $316.26
- OCREVUS (Biological) $309.09
- UBRELVY (Drug) $294.21
- Briviact (Drug) $281.40
- TROKENDI XR (Drug) $274.64
- Aimovig (Biological) $267.05
- LEMTRADA (Drug) $261.94
- Fycompa (Drug) $257.55
- EMGALITY (Drug) $233.08
- QULIPTA (Drug) $196.95
- Betaseron (Drug) $186.87
- INGREZZA (Drug) $180.94
- BOTOX CHRONIC MIGRAINE (Drug) $164.92
- KYNMOBI (Drug) $161.74
- AUSTEDO (Drug) $150.92
- Vimpat (Drug) $150.73
- EPIDIOLEX (Drug) $147.03
- TECFIDERA (Drug) $134.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Upland
William Baek, M.d, M.D
Neurology — Payments: $56,988
Neurology $56,988
Dr. Faisal Qazi, D.o, D.O
Neurology — Payments: $24,806
Neurology $24,806
Dr. Bhupatrai Desai, M.d, M.D
Neurology — Payments: $11,892
Neurology $11,892
Madhavi Gupta, Md, MD
Neurology — Payments: $295.75
Neurology $295.75
Craig Bogen, Md, MD
Neurology — Payments: $120.63
Neurology $120.63
Dr. Calvin Stafford, Md, MD
Neurology — Payments: $116.80
Neurology $116.80